Media release Andrew Lyall (Drew), founding President and CEO of BioCanRx, died this weekend, after he, his family and physicians waged a long fight against melanoma. He was 49. Drew’s influence on health research, especially the biomedical world of stem cell research, was strong and unmistakable – extraordinary because he was not… Read more »
